Arcadia Biosciences, Inc. (RKDA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Arcadia Biosciences, Inc. (RKDA) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

RKDA Cash Flow Statement

Arcadia Biosciences, Inc. (RKDA) cash flow statement — 14-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-319K	-1.1M	-861K	-257K	-2.03M	-1.59M	-2.21M	-1.75M	-2.46M	-3.21M	-4.14M	-2.88M	-4.8M	-3.47M	-2.36M	-3.37M	-3.37M	-4.88M	-6.66M	-8.27M
Operating CF Margin %	-22.11%	-99.91%	-95.56%	-19.74%	-139.73%	-132.33%	-181.66%	-113.99%	-188.06%	-325.23%	-354.27%	-222.26%	-369.93%	-281.33%	-235.6%	-214.71%	-87.22%	-151.71%	-306.77%	-347.98%
Operating CF Growth %	84.31%	30.79%	61.02%	85.33%	17.22%	50.53%	46.71%	39.27%	48.81%	7.39%	-75.93%	14.42%	-42.59%	29.05%	64.62%	59.23%	46.01%	-3.78%	1.35%	-19.5%
Net Income	-6.27M	-4.38M	-1.34M	856K	-4.46M	2.6M	-4.06M	-1.18M	1.06M	-947K	-452K	-639K	818K	-9.38M	-4.33M	-2.88M	-3.8M	-4.61M	-9.56M	-2.84M
Depreciation & Amortization	0	8K	2K	2K	15K	13K	21K	194K	34K	228K	222K	345K	67K	71K	86K	90K	141K	162K	209K	304K
Stock-Based Compensation	14K	15K	17K	53K	86K	78K	117K	0	102K	0	0	0	199K	212K	209K	314K	323K	260K	506K	354K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	5.76M	3.65M	-170K	-2M	2.98M	-3.58M	1.34M	-525K	-3.52M	-1.89M	-2.71M	-2.21M	-4.08M	5.75M	-530K	-1.27M	621K	175K	2.73M	-3.1M
Working Capital Changes	176K	-382K	626K	830K	-659K	-701K	379K	-239K	-138K	-598K	-1.21M	-381K	-1.8M	-115K	2.21M	368K	-653K	-872K	-547K	-2.98M
Change in Receivables	-134K	0	406K	176K	-224K	-193K	-317K	-111K	-88K	-246K	-65K	162K	7K	80K	1.13M	799K	65K	-1.4M	7K	-306K
Change in Inventory	-90K	372K	244K	33K	-204K	-381K	-70K	180K	137K	303K	-1.03M	-72K	-1.28M	-37K	47K	70K	332K	669K	268K	-2.02M
Change in Payables	288K	-719K	-227K	458K	-417K	-213K	416K	-107K	66K	-678K	-222K	-151K	0	-149K	133K	-643K	-49K	-198K	-1.34M	-111K
Cash from Investing	0	0	0	0	250K	500K	2.52M	180K	4.64M	0	52K	5K	-4.72M	315K	281K	341K	48K	747K	-70K	-204K
Capital Expenditures	0	0	0	0	0	0	0	0	-3K	-13K	0	0	-5K	0	-26K	0	-6K	-40K	-88K	-206K
CapEx % of Revenue	-	-	-	-	-	-	-	-	0.23%	1.32%	-	-	0.39%	-	2.6%	-	0.16%	1.24%	4.05%	8.67%
Acquisitions	0	0	0	0	0	0	0	180K	-2M	17K	73K	5K	284K	285K	284K	285K	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	250K	0	-8K	0	6.65M	-4K	0	0	-5M	30K	23K	56K	54K	787K	17K	2K
Cash from Financing	3.54M	1.79M	0	1K	0	5K	0	4K	0	5K	0	7K	0	5.5M	0	4.51M	0	4K	-114K	21K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-114K	-13K
Equity Issued (Net)	0	1.79M	0	1K	0	5K	0	4K	0	5K	0	7K	0	6M	0	5M	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	3.54M	0	0	0	0	0	0	0	0	0	0	0	0	-492K	0	-485K	0	4K	0	34K
Net Change in Cash	3.22M	695K	-861K	-256K	-1.78M	-1.08M	306K	-1.57M	2.19M	-3.2M	-4.09M	-2.87M	-9.51M	2.35M	-2.08M	1.49M	-3.32M	-4.13M	-6.84M	-8.45M
Free Cash Flow	-319K	-1.1M	-861K	-257K	-2.03M	-1.59M	-2.21M	-1.75M	-2.46M	-3.22M	-4.14M	-2.88M	-4.8M	-3.47M	-2.38M	-3.37M	-3.37M	-4.92M	-6.75M	-8.47M
FCF Margin %	-22.11%	-99.91%	-95.56%	-19.74%	-139.73%	-132.33%	-181.66%	-113.99%	-188.28%	-326.55%	-354.27%	-222.26%	-370.32%	-281.33%	-238.2%	-214.71%	-87.38%	-152.95%	-310.82%	-356.65%
FCF Growth %	84.31%	30.79%	61.02%	85.33%	17.32%	50.73%	46.71%	39.27%	48.8%	7.01%	-74.01%	14.42%	-42.48%	29.62%	64.7%	60.22%	47.83%	5.14%	4.26%	-17.56%
FCF per Share	-0.23	-0.80	-0.63	-0.19	-1.49	-1.16	-1.62	-1.28	-1.80	-2.37	-3.22	-2.12	-3.54	-4.01	-3.87	-5.49	-6.08	-8.88	-12.17	-15.28
FCF Conversion (FCF/Net Income)	0.05x	0.25x	0.64x	-0.30x	0.46x	-0.61x	0.54x	1.09x	-2.31x	1.32x	1.45x	1.12x	-5.83x	0.37x	0.56x	1.18x	0.89x	1.09x	0.72x	3.80x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1K	0	4K
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0